Integrative Machine Learning of Glioma and Coronary Artery Disease Reveals Key Tumour Immunological Links.

Journal: Journal of cellular and molecular medicine
PMID:

Abstract

It is critical to appreciate the role of the tumour-associated microenvironment (TME) in developing strategies for the effective therapy of cancer, as it is an important factor that determines the evolution and treatment response of tumours. This work combines machine learning and single-cell RNA sequencing (scRNA-seq) to explore the glioma tumour microenvironment's TME. With the help of genome-wide association studies (GWAS) and Mendelian randomization (MR), we found genetic variants associated with TME elements that affect cancer and cardiovascular disease outcomes. Using machine learning techniques high dimensional data was analysed to obtain new molecular sub-types and biomarkers that are important for prognosis and treatment response. F3 was identified as a top regulator and revealed potential angiogenic and immunogenic characteristics within the TME that could be harnessed in immunotherapy. These results demonstrate the potential of machine-learning approaches in identifying and dissecting TME heterogeneity and informing treatment in precision oncology. This work proposes improving the immunotherapeutic response through targeted modulation of relevant cellular and molecular interactions.

Authors

  • Youfu He
    Medical College, Guizhou University, Guiyang, Guizhou Province, China.
  • Ganhua You
    Department of Research, The Second People's Hospital of Guizhou Province, Guiyang, Guizhou Province, China.
  • Yu Zhou
    Department of Biospectroscopy, Leibniz-Institut für Analytische Wissenschaften - ISAS - e.V., Dortmund, Germany.
  • Liqiong Ai
    Office of Student Affairs, Guiyang Healthcare Vocational University, Guiyang, Guizhou Province, China.
  • Wei Liu
    Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, United States.
  • Xuantong Meng
    Department of Pathology, Army 79th Group Hospital, Liaoyang, Liaoning Province, China.
  • Qiang Wu
    Department of Radiotherapy, West China Hospital, Sichuan University, Chengdu, PR China; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, PR China.